In this issue:
- Lung cancer screening in the US
- Patients who present via the ED
- Quality improvement reporting
- Palliative care:
- Early delivery
- Stepped delivery
- HARMONi-A: Ivonescimab + chemotherapy
- ADRIATIC: Durvalumab post-chemoradiotherapy
- KEYNOTE-671: Pembrolizumab + chemotherapy
- Indigenous patients: Access to clinical services
- Nivolumab + ipilimumab for PD-L1-postive NSCLC
Please login below to download this issue (PDF)